Plus Therapeutics, Inc. (NASDAQ:PSTV) Receives Average Rating of “Moderate Buy” from Analysts
Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one […]
28 Dec 11:40 · The Markets Daily